We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The British government says it will conduct a massive review of how new medical devices and in vitro diagnostics are developed, with the aim of bringing products to market faster and speeding patient access. Read More
Danaher’s plan to snap up dental implant company Nobel BioCare and Roche’s purchase of InterMune helped drive a strong third quarter for life sciences mergers and acquisitions, a new report from PricewaterhouseCoopers shows. Read More
Devicemakers may need to redesign scores of products and change their sterilization methods if the Environmental Protection agency goes through with plans to classify ethylene oxide as carcinogenic when inhaled by humans. Read More
The British government is looking to speed new drugs to market and provide faster patient access to medicines, an initiative that some industry experts say should include reforms of the UK’s healthcare reimbursement body. Read More
Medtronic officials said Tuesday that a large donation to the Medtronic Foundation plus the ongoing acquisition of Covidien led to an 8 percent decline in earnings in the second-quarter of fiscal 2015 compared with the previous year. Read More
Minneapolis, Minn.-based Vascular Solutions will not get a state subsidy for job creation in the wake of a federal fraud indictment issued against the company and its CEO. Read More
A study on the optimal length of dual antiplatelet therapy following implantation of a drug-eluting stent shows that 30 months is better than one year in preventing certain adverse outcomes. Read More